Author: Dr. David Lowemann

Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease

Yiwei Qian, Xiaodong Yang, Shaoqing Xu, Chunyan Wu, Nan Qin, Sheng-Di Chen, Qin Xiao Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen […]

Published on May 24, 2018

Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer’s Disease

Ruth Alonso, Diana Pisa, Ana M. Fernández-Fernández, Luis Carrasco Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With a keen interest in exploring the untapped […]

Published on May 24, 2018

A Specific Reduction in Aβ1−42 vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer’s Disease From Meningitis and Multiple Sclerosis

Philipp Spitzer, Roland Lang, Timo J. Oberstein, Piotr Lewczuk, Natalia Ermann, Hagen B. Huttner, Ilias Masouris, Johannes Kornhuber, Uwe Ködel, Juan M. Maler Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement […]

Published on May 24, 2018